Source:http://linkedlifedata.com/resource/pubmed/id/15625186
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
2005-4-13
|
| pubmed:abstractText |
Sulfasalazine (SASP) has been reported to depress the fertility in men and experimental male animals, but the fundamental mechanisms of infertility caused by SASP are still unknown. This study was designed to investigate the mechanisms of infertility in rats treated with SASP at a dose of 600 mg/kg for 28 days, including monitoring of sperm motility using computer associated sperm analysis system and acrosome reaction by FITC-concanavalin A lectin staining. The sperm motility and acrosome reaction, which are important for fertilization, were significantly reduced by SASP. Furthermore, to investigate the molecular mechanisms of infertility induced by SASP, mRNA expression analysis in the testes was performed using cDNA microarray as a first screening. It was revealed that CD59, which is located on the acrosomal membrane and is known to be important for the reproductive function of sperm, was affected in the testes; this was also confirmed by real-time PCR analysis, but the spermatogenesis-related genes examined in this study were not affected. Therefore, we focused on CD59 and two other acrosome membrane related-genes: MCP and DAF. CD59, MCP, and DAF in the epididymides of SASP-treated rats were significantly decreased as assessed by real-time RT-PCR analysis and additionally, the expression of CD59 protein was found to be decreased by Western blotting. These results allowed us to hypothesize that the suppression of epididymal acrosomal membrane proteins synthesis with their consequent reduced incorporation to the sperm membrane leads to a depressed sperm motility and acrosome reaction, and thereby leads to infertility in SASP treated male rats.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
May
|
| pubmed:issn |
1096-6080
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
85
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
675-82
|
| pubmed:dateRevised |
2010-9-17
|
| pubmed:meshHeading |
pubmed-meshheading:15625186-Acrosome Reaction,
pubmed-meshheading:15625186-Animals,
pubmed-meshheading:15625186-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:15625186-Blotting, Western,
pubmed-meshheading:15625186-Female,
pubmed-meshheading:15625186-Fertility,
pubmed-meshheading:15625186-Gene Expression,
pubmed-meshheading:15625186-Gene Expression Profiling,
pubmed-meshheading:15625186-Genitalia, Male,
pubmed-meshheading:15625186-Male,
pubmed-meshheading:15625186-Membrane Glycoproteins,
pubmed-meshheading:15625186-Oligonucleotide Array Sequence Analysis,
pubmed-meshheading:15625186-RNA, Messenger,
pubmed-meshheading:15625186-Rats,
pubmed-meshheading:15625186-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:15625186-Sperm Motility,
pubmed-meshheading:15625186-Spermatozoa,
pubmed-meshheading:15625186-Sulfasalazine
|
| pubmed:year |
2005
|
| pubmed:articleTitle |
Effects of sulfasalazine on sperm acrosome reaction and gene expression in the male reproductive organs of rats.
|
| pubmed:affiliation |
Worldwide Safety Sciences, Nagoya Laboratories, Pfizer Japan Inc., 5-2, Taketoyo, Aichi 470-2393, Japan. tamio.fukushima@japan.pfizer.com
|
| pubmed:publicationType |
Journal Article
|